InsidersTradesSigma
Track the 仁和药业 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 仁和药业 has published 9 insider filings. Market capitalisation: €7.7bn. The latest transaction was disclosed on 1 November 2023 (Purchase). Among the most active insiders: 杨潇. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
仁和药业 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of medicines and health products.